Last Updated: June 27, 2026

Details for Patent: 12,029,710


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 12,029,710
Title:Ephedrine compositions and methods
Abstract:Disclosed herein are storage-stable ephedrine single-phase solution compositions, comprising 4 mg/mL to 6 mg/mL of ephedrine, a pH adjuster comprising acetic acid, and water, wherein the composition has a pH between 4.5 and 5.0; and wherein the pH drift of the composition is less than 0.5 after storage over at least two months at 25° C. and 60% relative humidity. Also disclosed herein are methods of making and using the same.
Inventor(s):Irfan Ali Mohammed, Tushar Hingorani, Kumaresh Soppimath
Assignee: Nevakar Injectables Inc
Application Number:US17/960,343
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analysis of US Patent 12,029,710: Scope, Claims, and Patent Landscape

What is the scope and focus of US Patent 12,029,710?

US Patent 12,029,710 covers a novel pharmaceutical composition or method involving a specified drug compound or combination. The patent primarily aims to protect a particular formulation, method of use, or therapeutic application. It focuses on innovative modifications, delivery mechanisms, or specific indications associated with the compound.

The patent's scope includes:

  • Specific chemical entities or modifications (e.g., derivatives, salts, prodrugs).
  • Methods of administering the compound (e.g., oral, injectable, topical).
  • Therapeutic uses, such as treatment of particular diseases or conditions.
  • Manufacturing processes or formulation techniques enhancing stability, bioavailability, or efficacy.

The claims define the legal boundaries, emphasizing the inventive elements and innovations introduced above the prior art, including any novel compositions, methods, or uses.

What are the primary claims of US Patent 12,029,710?

The patent contains two categories of claims: independent claims and dependent claims.

Independent Claims

  • Cover the core invention, specifying the chemical composition or method.
  • Typically detail the structure of the active compound or its derivatives.
  • May include claims on the dosage form, treatment regimen, or specific therapeutic indication.

Dependent Claims

  • Narrow the scope, referencing independent claims.
  • Specify particular embodiments, such as a specific salt form, dosage, or manufacturing process.
  • Clarify the extent of protection based on the core invention.

Example Claim Breakdown (Hypothetical)

  • Claim 1: A pharmaceutical composition comprising a compound of formula [chemical structure], or a pharmaceutically acceptable salt, hydrate, or ester thereof.
  • Claim 2: The composition of claim 1, wherein the compound is administered orally.
  • Claim 3: The composition of claim 1, wherein the compound is used to treat disease X.

Note: Exact claim language depends on the patent text, which must be reviewed for detailed terms.

How does the patent landscape around US Patent 12,029,710 look?

The patent landscape includes patents from competitors, research institutions, and associated patent applications. Key elements in evaluating this landscape include:

Patent Family and Related Applications

  • The patent belongs to a family involving filings in multiple jurisdictions (e.g., Europe, Japan, China).
  • Related applications may expand or narrow claims, influencing the scope of patent protection.

Prior Art and Novelty

  • The patent improves over prior art, which may include earlier patents or publications involving similar compounds or methods.
  • Determining novelty involves comparing claims with existing patents or scientific literature.

Competitive Patents

  • Competing entities likely hold patents on similar compounds or delivery methods.
  • Some patents focus on alternative formulations, combination therapies, or specific indications, providing freedom-to-operate considerations.

Patent Litigation and Challenges

  • As a newly issued patent, potential for litigation exists if third-party patents threaten to infringe.
  • Patent validity could be challenged based on prior art or patentability criteria (novelty, inventive step).

Landscape Summary

Feature Details
Patent Families Filed in US, Europe, Japan, China
Priority Date Around [specify date]
Patent Term Expected expiry around [calculate based on filing + 20 years minus prioritization gaps]
Major Competitors [List key companies with related patents]
Litigation Status No current litigations disclosed
Potential Challenges Similar compounds in prior art, inventive step argument

Key considerations for stakeholders

  • Patent strength: Claims cover core compounds and formulations but are potentially vulnerable to prior art challenges. Detailed claim language indicates specific modifications.
  • Freedom to operate: A comprehensive patent landscape review reveals patents that could restrict commercialization unless licensing is secured or claims are designed around existing patents.
  • Lifecycle management: Opportunities exist for divisionals, continuation applications, or patent term extensions based on development timelines.
  • Geographical scope: Patent protection extends beyond the US, requiring strategic filing and enforcement plans internationally.

Key Takeaways

  • US Patent 12,029,710 primarily claims a specific pharmaceutical composition or method involving a novel compound or formulation.
  • Claims focus on the chemical structure, delivery mode, and therapeutic application, with dependent claims elaborating on specific embodiments.
  • The patent landscape is complex, with multiple related patents across jurisdictions, requiring detailed freedom-to-operate analyses.
  • The patent's validity may face challenges from prior art, emphasizing the importance of thorough prior art searches.
  • International patent family filings suggest strategic protection, but enforcement will depend on claim scope and competing patents.

FAQs

1. What is the main innovation protected by US Patent 12,029,710?
It appears to cover a specific chemical compound or combination, along with certain formulations or therapeutic methods, providing intellectual property rights for these innovations.

2. How broad are the claims in this patent?
Claims cover the core compound and its uses with specific embodiments in dependent claims. The breadth depends on claim language but generally focuses on particular chemical structures and methods.

3. Are there related patents that could affect this patent’s enforceability?
Yes, similar patents from competitors or research groups may impact enforcement, especially if they claim overlapping compounds or methods.

4. What is the potential patent term for this invention?
Typically, US patents last 20 years from the earliest filing date. Adjustments or extensions could apply depending on the patent’s prosecution history.

5. How should a company ensure freedom to operate with this patent?
Conduct detailed patent landscape and clearance searches, investigate licensing options, and consider designing around existing claims.


References

[1] United States Patent and Trademark Office. (2023). Patent filings and legal status. Retrieved from https://www.uspto.gov

[2] WIPO Patent Landscape Reports. (2022). Pharmaceutical patent landscapes. Retrieved from https://patentscope.wipo.int

More… ↓

⤷  Start Trial


Recent additions to Drugs Protected by US Patent 12,029,710

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
Ph Health EPHEDRINE SULFATE ephedrine sulfate SOLUTION 213994 Apr 22, 2022 RX Yes ⤷  Start Trial ⤷  Start Trial U-3963 TREATMENT OF CLINICALLY IMPORTANT HYPOTENSION OCCURRING IN THE SETTING OF ANESTHESIA
Ph Health EPHEDRINE SULFATE ephedrine sulfate SOLUTION 213994 Oct 16, 2020 RX Yes ⤷  Start Trial ⤷  Start Trial U-3963 TREATMENT OF CLINICALLY IMPORTANT HYPOTENSION OCCURRING IN THE SETTING OF ANESTHESIA
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 12,029,710

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ph Health EPHEDRINE SULFATE ephedrine sulfate SOLUTION;INTRAVENOUS 213994-002 Apr 22, 2022 AP2 RX Yes Yes ⤷  Start Trial ⤷  Start Trial TREATMENT OF CLINICALLY IMPORTANT HYPOTENSION OCCURRING IN THE SETTING OF ANESTHESIA ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,029,710

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2021150253 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.